Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CGC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
32 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 14 days ago
Red flags: 0
213 filers reported a long position in CGC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Tidal Investments LLC | $8.7M | 9.2M | +8.4% |
| GFS Advisors, LLC | $6.7M | 27 | New |
| MORGAN STANLEY | $1.8M | 1.9M | -1.2% |
| LAZARD ASSET MANAGEMENT LLC | $1.8M | 1.8M | +2.2% |
| JANE STREET GROUP, LLC | $1.5M | 1.6M | -1.2% |
| UBS Group AG | $1.3M | 1.4M | +48.6% |
| GOLDMAN SACHS GROUP INC | $1.2M | 1.3M | +3.2% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.2M | 1.2M | +24.3% |
| ROYAL BANK OF CANADA | $1M | 1.1M | +10.9% |
| NATIONAL BANK OF CANADA /FI/ | $816K | 858.5K | +6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.